All stocks / RTGN
RetinalGenix Technologies Inc. RTGN
RetinalGenix Technologies (RTGN): a late 10-Q notice in November 2026 and the latest annual figures in plain language. Each fact links to its SEC filing.
Market listing
- Full name
- RETINALGENIX TECHNOLOGIES INC
- Market tier
- OTCQB
- Trading status
- Active
- Last trade
- Nov 12
News headlines
The financial report, and what it means
Annual figures to 2025-12-31- Net loss
- ($2,428,595)
It spends more than it earns
Under strainThe company lost $2.4 million in the year. It reported no sales.
- Cash and cash equivalents
- $14,774
- Net cash used in operating activities
- ($558,350)
The cash could run out soon
Under strainIt had $14,774 in the bank and used about $46,529 a month. At that pace the money lasts less than a month unless it borrows or sells more shares.
- Total assets
- $21,041
- Total liabilities
- $2,323,652
It owes more than it owns
Under strainEverything the company owns adds up to $21,041. Its debts and unpaid bills add up to $2.3 million. That is about $110.43 owed for every $1 owned.
What this adds up to
3 of 3 checks show strain. It spends more than it earns. The cash could run out soon. It owes more than it owns. These are facts from the company's own reports, not a recommendation.
Signals
Filed NT 10-Q on 2026-11-13: notice that a periodic report is late.
Rule: Late-filing notice (Form NT 10-K or NT 10-Q) in the last 12 months. Source record
Estimated float about 18,843,628 shares as of 2026-08-15: 18,843,628 outstanding minus 0 held by 0 reporting insider(s).
Rule: Estimated: shares outstanding minus the latest holdings insiders reported on Forms 3/4/5. Holders of 5% or more (13D/13G) are not yet subtracted. Source record
Filed NT 10-Q on 2026-05-15: notice that a periodic report is late.
Rule: Late-filing notice (Form NT 10-K or NT 10-Q) in the last 12 months. Source record
Filed NT 10-K on 2026-03-30: notice that a periodic report is late.
Rule: Late-filing notice (Form NT 10-K or NT 10-Q) in the last 12 months. Source record
Shares outstanding
Source: SEC filingsPrice chart
Chart by TradingView. We do not store or publish prices. Live quote on OTC Markets
Recent filings
Common questions about RTGN
Does RTGN file reports with the SEC?
Yes. RetinalGenix Technologies files with the SEC under company number 0001836295. The most recent filing we hold is a NT 10-Q dated 2026-11-13.
Source recordHow many RTGN shares are outstanding?
18,843,628 shares as of 2026-08-15, as reported to the SEC.
Source recordHas RTGN filed reports late?
Yes. In the last 12 months it filed 3 late-filing notices, most recently a NT 10-Q on 2026-11-13. A notice means a report was not ready on time; check whether the report followed.
Source recordIs RetinalGenix Technologies making money?
The company lost $2.4 million in the year. It reported no sales. (Annual figures to 2025-12-31. Facts from the company's own report, not a recommendation.)
Source record